Chronic total occlusion successfully treated with a bioresorbable everolimus-eluting vascular scaffold

Juan Carlos Rama-Merchan; Alessio Mattesini; Gianni Dall'Ara; Carlo Di Mario

doi:10.5114/pwki.2014.43521

Chronic total occlusion successfully treated with a bioresorbable everolimus-eluting vascular scaffold

Postepy Kardiol Interwencyjnej. 2014;10(2):128-9. doi: 10.5114/pwki.2014.43521. Epub 2014 Jun 26.

Authors

Juan Carlos Rama-Merchan¹, Alessio Mattesini¹, Gianni Dall'Ara¹, Carlo Di Mario¹

Affiliation

¹ Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and Harefield Trust, London, United Kingdom.

Abstract

Fully bioresorbable vascular scaffolds (BVS) are a new approach to the percutaneous treatment of coronary artery disease. The BVS have not yet been fully tested in complex lesions, including chronic total occlusion (CTO). We report a CTO case successfully treated with a second-generation bioabsorbable drug-eluting scaffold.

Keywords: bioresorbable vascular scaffold; chronic total occlusion.